ABSTRACT PURPOSE: Sleeve gastrectomy (SG) removes substantial part of the gastric mucosa, which produces ghrelin. This reduction is expected to force other organs, such as the duodenum, to compensate by increasing the number of ghrelin-producing cells. The purpose of this study was to evaluate whether this response occurs. METHODS: Twelve adult male, Wistar rats underwent SG and were reoperated 30 or 60 days after the initial surgery. During the second surgery, a segment of the duodenum was resected to count ghrelin cells using immunohistochemistry. In six animals, SG was not performed, and the duodenal segment served as a control for ghrelin cell counts. The ghrelin cell index (GCI), which is the number of ghrelin cells divided by the number of villi in each segment, was measured and used in statistical analysis by one-way analysis of variance (ANOVA). RESULTS: There were increases in the absolute numbers of cells 30 and 60 days after SG, but statistical analysis by ANOVA showed no significant difference between the groups. CONCLUSION: A compensatory increase in the number of duodenal immunopositive ghrelin cells did not occur as a response to sleeve gastrectomy.
Introduction
Ghrelin is a peptide produced mainly by the X/A-like cells of the gastric fundus. It exhibits strong growth hormone (GH)-releasing activity and this effect is mediated by activation of the GH secretagogue receptor type 1a (GHS-R 1a). This receptor is specific for a family of synthetic peptidyl and nonpeptidyl growth hormone secretagogues (GHS) 1 .
Ghrelin has other functions in the body such as influencing the pituitary gonadal axis, appetite stimulation, control of energy balance, influence of sleep and behavior, control of gastric motility and acid secretion, and influencing both pancreatic exocrine and endocrine functions and glucose metabolism. The actions on the cardiovascular system, some effects on the proliferation of neoplastic cells, and the effects on the immune system were also described 1 . Ghrelin is considered to be a gastrointestinal peptide that contributes to the regulation of many functions of the gutbrain axis. There is a strong possibility that ghrelin analogs acting as either agonists or antagonists might be clinically useful 1 .
Ghrelin was identified in 1999 in Japan as an endogenous ligand for the former orphan receptor GHS-R 1a. The discovery of this receptor occurred 20 years after the discovery of the specificbinding and synthetic GHS 1,2 .
The discovery of ghrelin is an important example of reverse pharmacology, which in this particular case, began with the synthesis of analogs and ended with the discovery of the natural ligand through the discovery of a natural receptor 1,2 .
The hydroxyl group of ghrelin has a serine residue (serine 3) that is acylated by n-octanoic acid. This acylation is essential for its binding to GHS-R 1a and for the GH-releasing ability of ghrelin. This acylation is also important for its other endocrine actions. Nonacylated ghrelin is present in human serum in greater quantities than acylated ghrelin. It is thought to have no endocrine function, but it is capable of exerting some nonendocrine actions such as cardiovascular and antiproliferative effects, which are most likely mediated by its binding to different GHS-R subtypes 1, 3 .
Another type of ghrelin, which is an endogenous ligand for GHS-R 1a, can be isolated from the endocrine mucosa of the stomach. This type is known as Des-Gln14 ghrelin and exhibits the same serine acylation but lacks one glutamine. There is no insertion of a foreign body (band), and the pylorus and the antral mill are preserved, which prevents dumping syndrome.
The hospitalization required after this procedure is shortened with the laparoscopic approach, and the patient can take oral medications and eventually undergo endoscopy Eighteen adult male Wistar rats weighing 250-350g were used in this experiment. The animals were randomly allocated into
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three groups of six rats each: controls (C), 30 days (30D) and 60 days (60D). All the animals were housed in individual plastic cages and were allowed to eat standard rat chow and tap (chlorinated)
water ad libitum.
Surgical procedures
Rats were anesthetized with an intramuscular injection of 100 mg/kg of ketamine and 10 mg/kg xylazine.
Group C animals were submitted to a midline laparotomy to remove the first 5 cm of the duodenum. The specimens were preserved in a buffered formaldehyde solution. The rats were euthanized by an intracardiac potassium chloride injection.
The 30D and 60D groups were submitted to a modification of a previously described technique of SG and the animals were euthanized as described for group C. All the procedures were performed under sterile conditions. The resected duodenum samples were immediately placed in a buffered 10% formalin solution.
Histopathological procedures
A middle longitudinal strip of the 5-cm duodenal segments, 2 mm wide (pancreatic side) was cut and divided into three sections (proximal, middle and distal) to fit on a single microscopic slide. The specimens were processed, and paraffin blocks were prepared to make slides for both hematoxylin-eosin and immunohistochemical staining.
Immunohistochemistry
Tissues were stained immunohistochemically using the labeled streptavidin biotin method (LSAB). Briefly, the specimens were deparaffinized, rehydrated and incubated with 0.3% hydrogen peroxide in methanol for 20 minutes to block endogenous peroxidase activity. Antigen retrieval was performed using citrate buffer (pH 6.0) for 40 minutes at 95-98°C, and the specimens were left to cool for 30 minutes at room temperature.
The specimens were incubated with primary rabbit anti-ghrelin SSPS statistics software (SSPS, Inc., IL, USA) was used for data processing.
Results
All the animals had solid food in their stomachs at the time of the reoperations.
Ghrelin immunopositive cells were only observed in the villi and crypts of the mucosal layer. Figures 1 and 2 show immunopositive duodenal ghrelin cells staining in villi and crypts. Table 1 shows the results for each group including the number of immunopositive ghrelin cells, the opened-type cell number, the villi number and the GCI. The number of opened-type cell was included in the totals for each group. An ANOVA test was used to analyze the possible differences among the groups, mainly between the control group and 30D and 60D groups ( Table 2) . Statistical analysis showed no significant compensatory increase in the number of ghrelin immunopositive cells in a duodenum sample of rats submitted to SG 30 and 60 days after the operation.
Discussion
We investigated the hypothesis that the rat duodenum could increase the number of ghrelin cells to compensate for the lack of gastric tissue containing ghrelin-producing cells after its removal by SG.
Human plasma levels of immunoreactive ghrelin are reduced to approximately half of the pre-gastrectomy values and gradually increase, which suggests that other tissues compensate for the loss of ghrelin production after gastrectomy 6 .
Reduced plasma levels of ghrelin in humans in the early postoperative period were observed. However, a compensatory increase in the plasma ghrelin levels, most likely due to production of ghrelin by other tissues, may limit the success of SG in the longer follow-up. It was reported that among tissues, the duodenum has the second greatest number of ghrelin cells 12, 13 .
It is well known that stem cells in intestinal crypts times more ghrelin per 1g of tissue than the duodenum, which is the next richest source 13 .
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We analyzed the first 5 cm of the duodenum in two .
Conclusion
A compensatory increase in the number of duodenal immunopositive ghrelin cells did not occur as a response to sleeve gastrectomy.
